Fosamax Plus D and Insulin Glargine (U-100) Vials
Determining the interaction of Fosamax Plus D and Insulin Glargine (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alendronate / cholecalciferol
Brand name: Fosamax Plus D
Synonyms: n.a.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosamax Plus D-Insulin Glargine (U-300) Pens
- Fosamax Plus D-Insulin glargine and lixisenatide
- Fosamax Plus D-Insulin glargine and lixisenatide Subcutaneous
- Fosamax Plus D-Insulin glargine, recombinant Subcutaneous
- Fosamax Plus D-Insulin glulisine
- Fosamax Plus D-Insulin Glulisine (Cartridges and Pens)
- Insulin Glargine (U-100) Vials-Fosamprenavir
- Insulin Glargine (U-100) Vials-Fosamprenavir Calcium
- Insulin Glargine (U-100) Vials-Fosamprenavir Oral Suspension
- Insulin Glargine (U-100) Vials-Fosamprenavir Tablets
- Insulin Glargine (U-100) Vials-Fosaprepitant
- Insulin Glargine (U-100) Vials-Fosaprepitant Injection